Showing results (1-10 of 89) with videos related to
Sort By:
Pageof 9
The Clinical Biochemist. Reviews|May 26, 2011
Drug dosing in renal diseaseMatthew P Doogue, Thomas M PolasekTherapeutic Advances in Drug Safety|August 2, 2014
Metabolic activation of clopidogrel: in vitro data provide conflicting evidence for the contributions of CYP2C19 and PON1Thomas M Polasek, Matthew P Doogue, John O MinersTherapeutic Advances in Drug Safety|June 2, 2018
Metformin treatment of type 2 diabetes mellitus in pregnancy: update on safety and efficacyThomas M Polasek, Matthew P Doogue, Tilenka R J ThynneBritish Journal of Clinical Pharmacology|January 13, 2011
Perpetrators of pharmacokinetic drug-drug interactions arising from altered cytochrome P450 activity: a criteria-based assessmentThomas M Polasek, Frank P Y Lin, John O Miners, et al.BMC Bioinformatics|April 23, 2011
BICEPP: an example-based statistical text mining method for predicting the binary characteristics of drugsFrank P Y Lin, Stephen Anthony, Thomas M Polasek, et al.European Journal of Clinical Pharmacology|August 4, 2009
Assessment of inter-individual variability in predicted phenytoin clearanceThomas M Polasek, Sebastian Polak, Matthew P Doogue, et al.European Journal of Clinical Pharmacology|July 17, 2014
Evaluation of felodipine as a potential perpetrator of pharmacokinetic drug-drug interactionsBen D Snyder, Andrew Rowland, Thomas M Polasek, et al.British Journal of Clinical Pharmacology|August 29, 2012
Predicted metabolic drug clearance with increasing adult ageThomas M Polasek, Farhaan Patel, Berit P Jensen, et al.The Clinical Biochemist. Reviews|February 19, 2009
Advances in biochemical screening for phaeochromocytoma using biogenic aminesMalcolm J Whiting, Matthew P DoogueAustralian Prescriber|October 30, 2025
Oral anticoagulation for adults with atrial fibrillation or venous thromboembolismPaul Kl Chin, Matthew P DooguePageof 9